0.045
-0.01 (-10.00%)
| Previous Close | 0.050 |
| Open | 0.045 |
| Volume | 77,200 |
| Avg. Volume (3M) | 896,393 |
| Market Cap | 96,895,752 |
| Price / Sales | 1.85 |
| Price / Book | 2.26 |
| 52 Weeks Range |
| Profit Margin | -13.37% |
| Operating Margin (TTM) | -33.44% |
| Diluted EPS (TTM) | 0.000 |
| Quarterly Revenue Growth (YOY) | -9.70% |
| Quarterly Earnings Growth (YOY) | 759.10% |
| Total Debt/Equity (MRQ) | 22.47% |
| Current Ratio (MRQ) | 2.27 |
| Operating Cash Flow (TTM) | 3.55 M |
| Levered Free Cash Flow (TTM) | -4.90 M |
| Return on Assets (TTM) | -5.21% |
| Return on Equity (TTM) | -15.41% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Software - Application (MY) | Mixed | Mixed |
| Software - Application (Global) | Bearish | Bearish | |
| Stock | NOVAMSC | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 0.13 |
|
Nova MSC Bhd is an investment holding company engaged in software research and development and the provision of e-business solutions through application software and professional services. The Group operates one segment, E-Business Solutions, covering software development, e-business solutions, and software-related consultancy services. Its products include Pavo for online submissions, Fornax for electronic plan checking, Vesalius for hospital functions, Avicenna for cloud-based patient management, EyScan for retinal photo analysis using SELENA+, and Dexie, a social robot for dementia care. The Company also provides consultancy, training, maintenance and customization services in Malaysia and Singapore. |
|
| Sector | Technology |
| Industry | Software - Application |
| Investment Style | Small Core |
| % Held by Insiders | 55.18% |
| % Held by Institutions | 0.73% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 27 Feb 2026 | Announcement | Quarterly rpt on consolidated results for the financial period ended 31/12/2025 |
| 26 Jan 2026 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR OOI KENG THYE |
| 22 Jan 2026 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR OOI KENG THYE |
| 20 Jan 2026 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR OOI KENG THYE |
| 12 Jan 2026 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR OOI KENG THYE |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |